Background: Many studies have found racial and socioeconomic variation in medical care
for a variety of conditions. Undertreatment of depression for individuals of all races is a …

Little is known about the prescribing pattern for antidepressant pharmacotherapy by
ethnicity. The present study was designed to determine the rates of office-based visits …

Abstract Background and Objective: Both the rate of diagnosis of depression in the US and
the rate of prescribing an antidepressant for its treatment have increased substantially over …

Objective: This study was undertaken to determine ethnicity/race-specific (white, black, and
Hispanic) population-adjusted rates of US office-based physician visits in which a diagnosis …

The objective of this study is to discern ethnic/race-specific (black, Hispanic, white)
population-adjusted rates of US office-based visits documenting a diagnosis of depression …

Context Antidepressants have recently become the most commonly prescribed class of
medications in the United States. Objective To compare sociodemographic and clinical …

Mentally ill Medicaid recipients represent a population that may be vulnerable to limited
access to adequate treatment for their mental illness. In this study, depressed Medicaid …

Objective: The purpose of this secondary data analysis was to describe racial-ethnic
disparities in receipt of depression treatment and treatment modality among adult Medicaid …

OBJECTIVE: There is evidence of disparities in depression treatment by factors such as age,
race or ethnicity, and type of insurance. The purpose of this study was to assess whether …

Objectives: To determine whether there were racial or ethnic disparities in the use of
antidepressants in low‐income elderly patients insured by Medicaid. Design: Examination of …